Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Genitourinary (GU)
Study Name
NRG-GU006: Phase II, Double-Blinded, Placebo-Controlled Randomized Trial Of Salvage Radiotherapy With Or Without Enhanced Anti-Androgen Therapy With Apalutamide In Recurrent Prostate Cancer (prostatectomy within 10 years of registration)
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT03371719?term=NRG-GU006&rank=1
Contact for Questions
Nurse - Tracy 517-364-2835

Site view: at a glance